Dissolvable hydrogel compositions for wound management and methods of use
The inventions provided herein relate to dissolvable hydrogel compositions and methods of uses, e.g., but not limited to, in wound management. Accordingly, methods for wound management involving the dissolvable hydrogel compositions are also provided herein. In some embodiments, the dissolvable hydrogel composition comprises an adhesive thioester hydrogel, which can facilitate adherence of the dissolvable hydrogen composition to a surface (e.g., a wound) and can be controllably dissolved later upon addition of a thiolate compound to release the dissolvable hydrogel composition from the surface (e.g., the wound).
1. A dissolvable hydrogel composition comprising: an adhesive hydrogel layer comprising a first water-soluble linear, branched and/or dendritic crosslinkable polymer and a second water-soluble linear, branched and/or dendritic crosslinkable polymer held together by covalent bonds formed between the first crosslinkable polymer and the second crosslinkable polymer, wherein the second crosslinkable polymer comprises at least two thioester linkages within its backbone.
2. The dissolvable hydrogel composition of claim 1 , wherein the linear crosslinkable polymer comprises polyesters, polyethers, polyglycerols, polypeptides, polyether-esters, polyamino acids, polyester-amines, polyurethanes, polycarbonates, polyamino alcohols, thiols, amines, N-hydroxysuccinimide (NHS) moieties, maleimide (MAL) moieties, or any combinations thereof.
3. The dissolvable hydrogel composition of claim 1 , wherein the branched crosslinkable polymer comprises polyesters, polyethers, polyglycerols, polypeptides, polyether-esters, polyamino acids, polyester-amines, polyurethanes, polycarbonates, polyamino alcohols, thiols, amines, N-hydroxysuccinimide (NHS) moieties, maleimide (MAL) moiety, or any combinations thereof.
4. The dissolvable hydrogel composition of claim 1 , wherein the dendritic crosslinkable polymer comprises polyesters, polyethers, polyglycerols, polypeptides, polyether-esters, polyamino acids, polyester-amines, polyurethanes, polycarbonates, polyamino alcohols, thiols, amines, N-hydroxysuccinimide (NHS) moieties, maleimide (MAL) moieties, or any combinations thereof.
5. The dissolvable hydrogel composition of claim 1 , wherein when both the first and second crosslinkable polymers are branched or dendritic crosslinkable polymers, at least one of the first and the second dendritic crosslinkable polymers does not comprise poly(ethylene glycol).
6. The dissolvable hydrogel composition of claim 1 , wherein the first crosslinkable polymer has a chemical structure selected from the group consisting of structure (i) to structure (xii) shown as follows:
and any combinations thereof; and wherein:
Q is independently selected from the group consisting of O, S, Se, NH, CH 2 , and any combination thereof;
R is selected from the group consisting of a hydrogen, straight or branched alkyl, cycloalkyl, aryl, olefin or alkene, alkyne, silyl, alkylsilyl, arylsilyl, alkylaryl or arylalkyl chain of 1-50 carbons, fluorocarbon, and any combinations thereof, wherein each alkyl, cycloalkyl, aryl, olefin, alkyne, silyl, alkylsilyl, arylsilyl, alkylaryl, fluorocarbon, or arylalkyl chain is optionally substituted internally or terminally by one or more hydroxyl, hydroxyether, carboxyl, carboxyester, carboxyamide, amino, mono- or di-substituted amino, thiol, thioester, sulfate, phosphate, phosphonate, halogen substituents, polyethylene glycol), poly(ethylene oxide), poly(hydroxyacid), a carbohydrate, a protein, a polypeptide, an amino acid, a nucleic acid, a nucleotide, a polynucleotide, a DNA segment, a RNA segment, a lipid, a polysaccharide, an antibody, a pharmaceutical agent, an epitope for a biological receptor; and any combinations thereof; when at least two R groups are in the same structure, R can be different from each other and
m, n, x, and y are each independently selected from an integer of 0-1000.
7. The dissolvable hydrogel composition of claim 1 , wherein said at least two crosslinking moieties comprise at least one N-hydroxysuccinimide (NHS) moiety or maleimide (MAL) moiety.
8. The dissolvable hydrogel composition of claim 1 , wherein said at least two crosslinking moieties comprise at least two N-hydroxysuccinimide (NHS) moieties or maleimide (MAL) moieties.
9. The dissolvable hydrogel composition of claim 1 , wherein the second crosslinkable polymer has a chemical structure selected from the group consisting of structure (xiii) to structure (xl) shown as follows:
and any combination thereof; and wherein
Q is independently selected from the group consisting of O, S, Se, NH, CH 2 , and any combination thereof;
R is selected from the group consisting of a hydrogen, straight or branched alkyl, cycloalkyl, aryl, olefin or alkene, alkyne, silyl, alkylsilyl, arylsilyl, alkylaryl or arylalkyl chain of 1-50 carbons, fluorocarbon, and any combinations thereof, wherein each alkyl, cycloalkyl, aryl, olefin, alkyne, silyl, alkylsilyl, arylsilyl, alkylaryl, fluorocarbon, or arylalkyl chain is optionally substituted internally or terminally by one or more hydroxyl, hydroxyether, carboxyl, carboxyester, carboxyamide, amino, mono- or di-substituted amino, thiol, thioester, sulfate, phosphate, phosphonate, halogen substituents; and any combinations thereof; when at least two R groups are in the same structure, R can be different from each other; and
m, n, x, y and z are each independently selected from an integer of 0-1000, and
wherein the second crosslinkable polymer comprises at least two thioester linkages within its backbone.
10. The dissolvable hydrogel composition of claim 6 , wherein R is selected from the group consisting of poly(ethylene glycol), poly(ethylene oxide), poly(hydroxyacid), a carbohydrate, a protein, a polypeptide, an amino acid, a nucleic acid, a nucleotide, a polynucleotide, a DNA segment, a RNA segment, a lipid, a polysaccharide, an antibody, a pharmaceutical agent, an epitope for a biological receptor, and any combinations thereof.
11. The dissolvable hydrogel composition of claim 1 , wherein the first crosslinkable polymer has a chemical structure as follows:
12. The dissolvable hydrogel composition of claim 1 , wherein:
(i) the adhesive hydrogel layer is at least partially flexible;
(ii) the adhesive hydrogel layer is capable of withstanding a pressure of at least about 2 mmHg;
(iii) the adhesive hydrogel layer is transparent;
(iv) the adhesive hydrogel layer is hydrophilic; or
(v) any combination of (i)-(iv).
13. The dissolvable hydrogel composition of claim 1 , wherein the adhesive hydrogel layer has about 5 wt % to about 70 wt % of the crosslinkable polymers.
14. The dissolvable hydrogel composition of claim 1 , further comprising a bioactive agent.
15. The dissolvable hydrogel composition of claim 14 , wherein the bioactive agent is selected from the group consisting of pharmaceutical agents, drugs, cells, gases and gaseous precursors, synthetic organic molecules, proteins, enzymes, growth factors, vitamins, steroids, polyanions, nucleosides, nucleotides, polynucleotides, nanoparticles, diagnostic agents, genetic materials, and any combinations thereof.
16. The dissolvable hydrogel composition of claim 1 , wherein the adhesive layer is hydrolytically stable at pH in a range of about 0 to at least about 9.
17. The dissolvable hydrogel composition of claim 1 , wherein the dissolvable hydrogel composition is formulated to form a bandage, glue, sealant, dressing, scaffold, coating, or covering.
18. A kit comprising:
a dissolvable hydrogel composition of claim 1 .
19. The kit of claim 18 ,
wherein the first crosslinkable polymer is at least about 200 Da and wherein the second crosslinkable polymer is at least about 200 Da.
20. A method comprising:
(a) contacting a wound with a hydrogel composition of claim 1 ; and
(b) allowing the dissolvable hydrogel layer to adhere to tissue surrounding the wound.